| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 26.97▲ | 26.97▲ | 26.97▲ | 26.98▼ | 26.94▼ |
| MA10 | 27.17▼ | 27.18▼ | 27.18▼ | 27.07▼ | N/A |
| MA20 | 27.23▼ | 27.23▼ | 27.23▼ | 27.00▼ | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.119▼ | -0.147▼ | N/A | N/A | N/A |
| RSI | 56.283▲ | 57.860▲ | 58.468▲ | 53.398▲ | N/A |
| STOCH | 20.330 | 25.799 | 25.799 | 32.410 | N/A |
| WILL %R | -45.205 | -45.205 | -45.205 | -93.488▼ | N/A |
| CCI | -18.484 | -8.585 | -8.585 | -86.029 | N/A |
|
Tuesday, March 31, 2026 03:00 AM
SQQQProShares Trust - ProShares UltraPro Short Qqq$53.23-0.04% ...
|
|
Tuesday, March 08, 2022 08:30 AM
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from ...
|
|
Monday, January 03, 2022 11:00 PM
CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for cancer patients suffering ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 26.925 | 26.945 | 26.7934 | 26.7934 | 3,277 |
| 21/05/26 | 26.785 | 27.1499 | 26.785 | 26.9556 | 4,545 |
| 20/05/26 | 26.81 | 26.9752 | 26.74 | 26.9752 | 8,630 |
| 19/05/26 | 27.03 | 27.09 | 26.89 | 26.9145 | 158,213 |
| 18/05/26 | 27.56 | 27.56 | 27.24 | 27.2834 | 1,897 |
| 15/05/26 | 27.21 | 27.29 | 27.1576 | 27.1576 | 1,945 |
| 14/05/26 | 27.42 | 27.48 | 27.38 | 27.4088 | 5,563 |
| 13/05/26 | 27.195 | 27.47 | 27.195 | 27.405 | 5,177 |
| 12/05/26 | 26.81 | 26.9284 | 26.77 | 26.9284 | 5,227 |
| 11/05/26 | 27.115 | 27.115 | 26.8809 | 26.8809 | 3,343 |
|
|
||||
|
|
||||
|
|